Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2013Molecular Cancer TherapeuticsOpen Access

Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK

View Full Paper
Ask AI
Bookmark
Share

Authors

HVHarina VinGCGrace ChingSOSandra S. Ojeda

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vin et al. (2013) studied this question.

synapsesocial.com/papers/6a7dd3c2ac8a0219183c9b41https://doi.org/10.1158/1535-7163.mct-13-0561
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prospective Study of the Cutaneous Adverse Effects of Sorafenib, a Novel Multikinase Inhibitor2008 · 227 citations
  2. 2Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib2012 · 2,162 citations
  3. 3BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis2004 · 4,060 citations